S. 1132 · 117th Congress
EPI Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
KennedySponsorNo cosponsors.
This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.
What it does: CRS summary · Introduced in Senate · Apr 15, 2021
Ending Pricey Insulin Act or the EPI Act
This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.
Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement.
This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals.
The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: EPI Act
Also known as: Ending Pricey Insulin Act
Latest action (Apr 15, 2021): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Apr 15, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.